Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Submitted by
admin
on February 13, 2010 - 11:30am
Source:
Medical News Today
News Tags:
stem cells
leukemia
lymphoma
StemEx
Headline:
Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Do Not Allow Advertisers to Use My Personal information
